MKS (NASDAQ:MKSI) Price Target Raised to $170.00

MKS (NASDAQ:MKSI) had its price objective raised by equities researchers at Needham & Company LLC from $136.00 to $170.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the scientific and technical instruments company’s stock. Needham & Company LLC’s price target points to a potential upside of 11.01% from the stock’s previous close.

A number of other research analysts have also recently issued reports on MKSI. Deutsche Bank Aktiengesellschaft set a $175.00 target price on shares of MKS and gave the company a “buy” rating in a research note on Friday, October 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of MKS in a research note on Wednesday, October 8th. The Goldman Sachs Group upped their price objective on shares of MKS from $92.00 to $125.00 and gave the company a “sell” rating in a report on Thursday, October 9th. Morgan Stanley reiterated an “overweight” rating and set a $151.00 target price on shares of MKS in a research note on Monday, October 13th. Finally, Wall Street Zen upgraded shares of MKS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, September 20th. Eight investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, MKS currently has an average rating of “Moderate Buy” and a consensus price target of $140.60.

MKS Stock Performance

Shares of MKS stock traded up $13.22 during midday trading on Thursday, hitting $153.14. The company had a trading volume of 1,042,048 shares, compared to its average volume of 1,190,242. MKS has a 1-year low of $54.84 and a 1-year high of $155.88. The stock has a market cap of $10.28 billion, a PE ratio of 39.01, a P/E/G ratio of 1.63 and a beta of 2.00. The business’s 50 day simple moving average is $126.73 and its two-hundred day simple moving average is $104.49. The company has a debt-to-equity ratio of 1.71, a current ratio of 2.99 and a quick ratio of 1.88.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.80 by $0.13. MKS had a return on equity of 20.65% and a net margin of 7.11%.The firm had revenue of $988.00 million during the quarter, compared to analysts’ expectations of $963.87 million. During the same quarter in the prior year, the firm posted $1.72 EPS. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, equities analysts predict that MKS will post 6.94 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Elizabeth Mora sold 300 shares of MKS stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $99.85, for a total transaction of $29,955.00. Following the sale, the director directly owned 19,263 shares in the company, valued at $1,923,410.55. The trade was a 1.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP David Philip Henry sold 5,000 shares of the business’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $130.00, for a total value of $650,000.00. Following the completion of the sale, the executive vice president owned 15,571 shares in the company, valued at approximately $2,024,230. The trade was a 24.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 5,600 shares of company stock worth $716,597 in the last ninety days. Corporate insiders own 0.51% of the company’s stock.

Institutional Trading of MKS

Hedge funds have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD grew its position in MKS by 5.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,515,373 shares of the scientific and technical instruments company’s stock valued at $281,758,000 after acquiring an additional 173,945 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of MKS by 9.7% during the first quarter. Victory Capital Management Inc. now owns 3,388,639 shares of the scientific and technical instruments company’s stock valued at $271,599,000 after purchasing an additional 300,356 shares during the period. Wellington Management Group LLP raised its holdings in MKS by 41.8% during the 1st quarter. Wellington Management Group LLP now owns 3,250,085 shares of the scientific and technical instruments company’s stock valued at $260,494,000 after buying an additional 958,607 shares during the last quarter. Madison Asset Management LLC raised its stake in shares of MKS by 52.9% during the first quarter. Madison Asset Management LLC now owns 1,428,143 shares of the scientific and technical instruments company’s stock valued at $114,466,000 after acquiring an additional 494,207 shares during the last quarter. Finally, Cooke & Bieler LP raised its position in MKS by 7.7% during the 3rd quarter. Cooke & Bieler LP now owns 1,321,877 shares of the scientific and technical instruments company’s stock valued at $163,609,000 after purchasing an additional 94,692 shares during the last quarter. 99.79% of the stock is owned by institutional investors.

About MKS

MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.